255 related articles for article (PubMed ID: 15748883)
1. Geranylgeranylated, but not farnesylated, RhoB suppresses Ras transformation of NIH-3T3 cells.
Mazières J; Tillement V; Allal C; Clanet C; Bobin L; Chen Z; Sebti SM; Favre G; Pradines A
Exp Cell Res; 2005 Apr; 304(2):354-64. PubMed ID: 15748883
[TBL] [Abstract][Full Text] [Related]
2. EGFR, ErbB2 and Ras but not Src suppress RhoB expression while ectopic expression of RhoB antagonizes oncogene-mediated transformation.
Jiang K; Delarue FL; Sebti SM
Oncogene; 2004 Feb; 23(5):1136-45. PubMed ID: 14647415
[TBL] [Abstract][Full Text] [Related]
3. Transformation-selective apoptotic program triggered by farnesyltransferase inhibitors requires Bin1.
DuHadaway JB; Du W; Donover S; Baker J; Liu AX; Sharp DM; Muller AJ; Prendergast GC
Oncogene; 2003 Jun; 22(23):3578-88. PubMed ID: 12789266
[TBL] [Abstract][Full Text] [Related]
4. Akt mediates Ras downregulation of RhoB, a suppressor of transformation, invasion, and metastasis.
Jiang K; Sun J; Cheng J; Djeu JY; Wei S; Sebti S
Mol Cell Biol; 2004 Jun; 24(12):5565-76. PubMed ID: 15169915
[TBL] [Abstract][Full Text] [Related]
5. Geranylgeranylated RhoB mediates suppression of human tumor cell growth by farnesyltransferase inhibitors.
Du W; Prendergast GC
Cancer Res; 1999 Nov; 59(21):5492-6. PubMed ID: 10554025
[TBL] [Abstract][Full Text] [Related]
6. Farnesylated RhoB inhibits radiation-induced mitotic cell death and controls radiation-induced centrosome overduplication.
Milia J; Teyssier F; Dalenc F; Ader I; Delmas C; Pradines A; Lajoie-Mazenc I; Baron R; Bonnet J; Cohen-Jonathan E; Favre G; Toulas C
Cell Death Differ; 2005 May; 12(5):492-501. PubMed ID: 15776002
[TBL] [Abstract][Full Text] [Related]
7. ROCK I-mediated activation of NF-kappaB by RhoB.
Rodriguez PL; Sahay S; Olabisi OO; Whitehead IP
Cell Signal; 2007 Nov; 19(11):2361-9. PubMed ID: 17728102
[TBL] [Abstract][Full Text] [Related]
8. Both farnesylated and geranylgeranylated RhoB inhibit malignant transformation and suppress human tumor growth in nude mice.
Chen Z; Sun J; Pradines A; Favre G; Adnane J; Sebti SM
J Biol Chem; 2000 Jun; 275(24):17974-8. PubMed ID: 10770919
[TBL] [Abstract][Full Text] [Related]
9. Farnesyltransferase inhibitors disrupt EGF receptor traffic through modulation of the RhoB GTPase.
Wherlock M; Gampel A; Futter C; Mellor H
J Cell Sci; 2004 Jul; 117(Pt 15):3221-31. PubMed ID: 15226397
[TBL] [Abstract][Full Text] [Related]
10. Cell and tissue-type specific expression of Ras-related GTPase RhoB.
Fritz G; Gnad R; Kaina B
Anticancer Res; 1999; 19(3A):1681-8. PubMed ID: 10470101
[TBL] [Abstract][Full Text] [Related]
11. Analysis of Ras-induced oncogenic transformation of NIH-3T3 cells using differential-display 2-DE proteomics.
Ji H; Moritz RL; Kim YS; Zhu HJ; Simpson RJ
Electrophoresis; 2007 Jun; 28(12):1997-2008. PubMed ID: 17526045
[TBL] [Abstract][Full Text] [Related]
12. Farnesyltransferase inhibitors are inhibitors of Ras but not R-Ras2/TC21, transformation.
Carboni JM; Yan N; Cox AD; Bustelo X; Graham SM; Lynch MJ; Weinmann R; Seizinger BR; Der CJ; Barbacid M
Oncogene; 1995 May; 10(10):1905-13. PubMed ID: 7761092
[TBL] [Abstract][Full Text] [Related]
13. Rapamycin inhibits Akt-mediated oncogenic transformation and tumor growth.
Liu X; Powlas J; Shi Y; Oleksijew AX; Shoemaker AR; De Jong R; Oltersdorf T; Giranda VL; Luo Y
Anticancer Res; 2004; 24(5A):2697-704. PubMed ID: 15517874
[TBL] [Abstract][Full Text] [Related]
14. Induction of p202, a modulator of apoptosis, during oncogenic transformation of NIH 3T3 cells by activated H-Ras (Q61L) contributes to cell survival.
Xin H; Geng Y; Pramanik R; Choubey D
J Cell Biochem; 2003 Jan; 88(1):191-204. PubMed ID: 12461788
[TBL] [Abstract][Full Text] [Related]
15. Ras and RhoA suppress whereas RhoB enhances cytokine-induced transcription of nitric oxide synthase-2 in human normal liver AKN-1 cells and lung cancer A-549 cells.
Delarue FL; Taylor BS; Sebti SM
Oncogene; 2001 Oct; 20(45):6531-7. PubMed ID: 11641777
[TBL] [Abstract][Full Text] [Related]
16. c-Jun NH2-terminal kinase 2 is required for Ras transformation independently of activator protein 1.
Nielsen C; Thastrup J; Bøttzauw T; Jäättelä M; Kallunki T
Cancer Res; 2007 Jan; 67(1):178-85. PubMed ID: 17210697
[TBL] [Abstract][Full Text] [Related]
17. Gallic acid inhibits gastric cancer cells metastasis and invasive growth via increased expression of RhoB, downregulation of AKT/small GTPase signals and inhibition of NF-κB activity.
Ho HH; Chang CS; Ho WC; Liao SY; Lin WL; Wang CJ
Toxicol Appl Pharmacol; 2013 Jan; 266(1):76-85. PubMed ID: 23153558
[TBL] [Abstract][Full Text] [Related]
18. Cell growth inhibition by farnesyltransferase inhibitors is mediated by gain of geranylgeranylated RhoB.
Du W; Lebowitz PF; Prendergast GC
Mol Cell Biol; 1999 Mar; 19(3):1831-40. PubMed ID: 10022870
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of the immediate early gene product RhoB by exoenzyme C3 from Clostridium limosum and toxin B from Clostridium difficile.
Huelsenbeck J; Dreger SC; Gerhard R; Fritz G; Just I; Genth H
Biochemistry; 2007 Apr; 46(16):4923-31. PubMed ID: 17397186
[TBL] [Abstract][Full Text] [Related]
20. A Proteomic approach for protein-profiling the oncogenic ras induced transformation (H-, K-, and N-Ras) in NIH/3T3 mouse embryonic fibroblasts.
Kim S; Lee YZ; Kim YS; Bahk YY
Proteomics; 2008 Aug; 8(15):3082-93. PubMed ID: 18601226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
